Buy Methylergobrevin ampoules 0.2 mg/ml, 1 ml, 50 pcs
  • Buy Methylergobrevin ampoules 0.2 mg/ml, 1 ml, 50 pcs

Methylergometrine

Hemofarm
Dosage form
Brand & Manufacturer
Package Size
$46.25
Quantity
There are not enough products in stock
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Methylergobrevin has a uterotonic effect. Increases the tone of the myometrium, helps to stop uterine bleeding.

Indications

The second stage of labor, atonic uterine bleeding, subinvolution of the uterus, lochyometer.

Composition

Methylergometrine

No customer reviews for the moment.

Write your review

Write your review

Methylergometrine

Dosage and Administration

Methylergobrevin administered IV, IM, SubQ. With the active management of the second stage of labor, 0.1–0.2 mg (0.5–1 ml) is introduced into / after the appearance of the anterior part of the fetal shoulder (1 ml is recommended under conditions of general anesthesia). With atonic uterine bleeding - 0.2 mg (1 ml) i / m or 0.1-0.2 mg (0.5-1 ml i / v; if necessary, repeat injections with an interval of 2 hours. Uterine Subinvolution Therapy, lohiiometry - 0.1-0.2 mg (0.5-1 ml) s / c or IM up to 3 times a day.At a caesarean section, it is administered after the fetus is extracted into / in, at 0.05-0.1 mg or IM at 0.2 mg For abortions (after dilation of the cervical canal) IV - 0.1-0.2 mg, with spontaneous abortions IV - 0.05-0.1 mg.

Adverse reactions

Abdominal pain, nausea, vomiting, increased sweating, dizziness, headache, increased blood pressure, bradycardia or tachycardia, peripheral vasospasm, decreased milk secretion, allergic reactions (skin rash), anaphylactic shock.

Contraindications

Hypersensitivity, severe hypertension, vascular occlusive disease, sepsis, pregnancy, the first stage of labor.

Special instructions

In the treatment and prevention of atonic uterine bleeding effective combination of methylergobrevin with oxytocin. Methyl erbobrevin may enhance the vasoconstrictor vasopressor effects of sympathomimetics and ergotamine. The use of the drug for breastfeeding is not recommended.

  • Active ingredient: Methylergometrine

Studies and clinical trials of Methylergometrine (Click to expand)

  1. Methylergometrine during the early puerperium; a prospective randomized double blind study
  2. Methylergometrine, an active metabolite of methysergide
  3. Methylergometrine antagonizes 5 HT in the temporal artery
  4. Pharmacokinetics of methysergide and its metabolite methylergometrine in man
  5. Methylergometrine-induced myocardial ischemia in a previously asymptomatic premenopausal woman
  6. Effects of haloperidol, methylergometrine and phentolamine on the frog ERG
  7. Misoprostol versus methylergometrine: farmacokinetiek in moedermelk
  8. Reversible cerebral vasoconstriction syndrome with limb myoclonus following intravenous administration of methylergometrine
  9. Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor
  10. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double–blind randomised trial
  11. Pharmacokinetics of Methylergometrine in the Rat: Evidence for Enterohepatic Recirculation by a Linked-Rat Model
  12. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor
  13. Distribution of methylergometrine in the breast milk of dogs
  14. Comparative effects of oral molsidomine and nifedipine on methylergometrine-induced coronary artery spasm
  15. Misoprostol versus methylergometrine: Pharmacokinetics in human milk
  16. Bromocriptin and methylergometrine : Pharmacological approach of the mechanism of their central effects
  17. Ergometrine and methylergometrine tablets are not stable under simulated tropical conditions
  18. Pharmacological Studies of Ergometrine and Methylergometrine.
  19. Pharmacokinetics of Methylergometrine (Methylergonovine) in the Rabbit and Man
  20. Pharmacokinetics of Methylergometrine (Methylergonovine) in the Rabbit and Man
  21. Plasma and Tissue Concentrations of Methylergometrine (Methylergonovine) in the Rabbit
  22. Prophylactic effect of intravenous tiapamil on methylergometrine-induced coronary artery spasm in patients with variant angina: Randomized double-blind trial
  23. Effect of estradiol 17β upon coronary artery vasoconstrictor response to methylergometrine maleate in female menopausal patients

8 other products in the same category:

arrow_upward